CET Services

Cellular Engineering Technologies (CET) is a biotechnology company specializing in the development of next-generation cell manufacturing technologies and contract research services. The company focuses on induced pluripotent stem cell (iPSC) technology, providing high-quality human-derived cell lines and specialized cell culture media designed to improve the safety and efficiency of regenerative medicine. CET offers a range of contract research services (CRO), including custom cell line development, protein expression, and drug discovery assays. Their proprietary, virus-free reprogramming methods aim to reduce neoplastic risk in cell-based therapies, positioning the company as a key provider for researchers and pharmaceutical companies working on treatments for neurodegenerative diseases and cancer.